Cargando…

Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis

PURPOSE: Insulin resistance (IR) has an important role in the development of non-alcoholic steatohepatitis (NASH). We aimed to analyze the association between liver histopathology and IR in pediatric patients with NASH. MATERIALS AND METHODS: In 24 children with non-alcoholic fatty liver disease (NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Byung Han, Yoon, Jung Min, Kim, Ja Hye, Moon, Jin-Hwa, Lee, Young Ho, Jang, Se Min, Kim, Yong Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447106/ https://www.ncbi.nlm.nih.gov/pubmed/28540988 http://dx.doi.org/10.3349/ymj.2017.58.4.756

Ejemplares similares

Investigation of Clinical and Pathological Relationships between Adult- and Pediatric-type NASH in Korean Children
por: Yoon, Jungmin, et al.
Publicado: (2017)

Erratum to “Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis” by Park BH, et al. (Yonsei Med J 2017;58:756–762.)
Publicado: (2018)

The Association between Alcohol Consumption and β-Cell Function and Insulin Sensitivity in Korean Population
por: Yoo, Min-Gyu, et al.
Publicado: (2016)

Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis
por: Kwon, Young Dai, et al.
Publicado: (2019)

Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome
por: Yang, Gabsik, et al.
Publicado: (2020)

Metabolic improvement and liver regeneration by inhibiting CXXC5 function for non-alcoholic steatohepatitis treatment
por: Seo, Seol Hwa, et al.
Publicado: (2022)

Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
por: Park, Jung Gil, et al.
Publicado: (2020)

Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis
por: Bhardwaj, Rishi R., et al.
Publicado: (2010)

Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
por: Kim, Jimin, et al.
Publicado: (2021)

Spirulina platensis and its ingredient biopterin glucoside improved insulin sensitivity in non-alcoholic steatohepatitis model
por: Fujihara, Yuri, et al.
Publicado: (2021)

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
por: Dennis, Andrea, et al.
Publicado: (2021)

Correlation of Clinical and Histopathologic Parameters with Ultrasonographic Grades in Pediatric Non-Alcoholic Fatty Liver Disease
por: Kang, Bo-Kyeong, et al.
Publicado: (2019)

Plasma Metabolomics and Machine Learning-Driven Novel Diagnostic Signature for Non-Alcoholic Steatohepatitis
por: Ji, Moongi, et al.
Publicado: (2022)

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis
por: Kim, Hyeong Geug, et al.
Publicado: (2021)

Clinical outcomes in pediatric patients with normal renal histopathology
por: Kwak, Naeun, et al.
Publicado: (2022)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Effects of Coffee Consumption on Insulin Resistance and Sensitivity: A Meta-Analysis
por: Moon, Su-Min, et al.
Publicado: (2021)

Correlation between Transient Elastography (Fibroscan(®)) and Ultrasonographic and Computed Tomographic Grading in Pediatric Nonalcoholic Steatohepatitis
por: Lee, Ji Eun, et al.
Publicado: (2022)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
por: Armstrong, M J, et al.
Publicado: (2014)

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
por: Macias, Juan, et al.
Publicado: (2022)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

NEFA‐induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non‐alcoholic steatohepatitis
por: Gao, Wenwen, et al.
Publicado: (2018)

Effect of telmisartan and vitamin E on liver histopathology with non‐alcoholic steatohepatitis: A randomized, open‐label, noninferiority trial
por: Alam, Shahinul, et al.
Publicado: (2020)

Age-related sensitivity to endotoxin-induced liver inflammation: Implication of inflammasome/IL-1β for steatohepatitis
por: Chung, Ki Wung, et al.
Publicado: (2015)

Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice
por: Park, Han-Sol, et al.
Publicado: (2016)

Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice
por: Verbeek, Jef, et al.
Publicado: (2017)

Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis
por: Liu, Feng, et al.
Publicado: (2022)

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
por: Hwang, Kyu Ri, et al.
Publicado: (2013)

Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy
por: Sim, Eun Hui, et al.
Publicado: (2012)

GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress
por: Kim, Hyeon Ju, et al.
Publicado: (2020)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Accuracy of proton magnetic resonance for diagnosing non-alcoholic steatohepatitis: a meta-analysis
por: Kim, Tae-Hoon, et al.
Publicado: (2019)

Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
por: Lee, Jin Ha, et al.
Publicado: (2020)

Severe Phenotype of Non-alcoholic Fatty Liver Disease in Pediatric Patients with Subclinical Hypothyroidism: a Retrospective Multicenter Study from Korea
por: Choi, So Yoon, et al.
Publicado: (2021)

Protective Effect of Lactobacillus fermentum LA12 in an Alcohol-Induced Rat Model of Alcoholic Steatohepatitis
por: Kim, Byoung-Kook, et al.
Publicado: (2017)

Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease
por: Furthner, Dieter, et al.
Publicado: (2022)

Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
por: Brar, Gurmehr, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2cp6r0d2pj9smd30eufvm7f6ko